Skip to main content
Equibles

683 Capital Management, LLC

Position in IVVD — Invivyd, Inc.

CIK 1404574 NEW YORK, NY
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,164,777
-$1,104,723 QoQ
Shares Held
2,482,543
-1.3% QoQ
Ownership
0.842%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#22
of 124 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names. IVVD ranks #25 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ANAB
Anaptysbio, Inc
 660,000 $44,550,000
2 PTGX
Protagonist Therapeutics, Inc
 290,000 $35,548,200
3 MGTX
MeiraGTx Holdings plc
 2,300,000 $31,073,000
4 WVE
Wave Life Sciences, Inc.
 4,950,000 $28,759,500
5 QURE
uniQure N.V.
 575,000 $26,484,500
6 TGTX
Tg Therapeutics, Inc.
 389,081 $21,376,110
7 PHAT
Phathom Pharmaceuticals, Inc.
 1,850,000 $20,072,500
8 TRAX
First Tracks Biotherapeutics, Inc.
 750,000 $15,090,000

All Filings in IVVD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,164,777 2,482,543
2026-03-31 $3,269,500 2,515,000
2025-12-31 $7,163,000 2,900,000
2025-09-30 $6,930,000 6,300,000
2025-06-30 $2,195,050 3,070,000
2025-03-31 $1,815,000 3,000,000
2024-12-31 $1,329,000 3,000,000
2024-09-30 $3,060,000 3,000,000
2024-06-30 $3,987,500 3,625,000
2024-03-31 $15,429,000 3,475,000
2023-12-31 $14,184,000 3,600,000
2023-09-30 $6,800,000 4,000,000
2023-06-30 $4,200,000 4,000,000
2023-03-31 $4,080,000 3,400,000
2022-12-31 $4,500,000 3,000,000
2022-09-30 $10,610,700 3,390,000
2022-06-30 $11,819,929 3,603,637
2022-03-31 $10,716,000 2,350,000
2021-12-31 $4,501,200 620,000